AI brief of an SEC Form 8-K · Eastman Chemical (EMN)

Eastman Q1 adjusted EPS rises 19% to $1.91; sales dip 1% and cash use grows

Mixed Impact 4 of 5 earnings Written later

Eastman reported first-quarter 2025 sales of $2.29 billion, down 1% from a year earlier, while adjusted earnings per share rose 19% to $1.91 and GAAP diluted EPS rose to $1.57 from $1.39. Cash used in operations widened to $167 million, and the company moved to quarterly adjusted EPS guidance, forecasting second-quarter adjusted EPS of $1.70 to $1.90 amid tariff uncertainty, while cutting its capital expenditure target to around $550 million.

Key points

  • Adjusted EPS of $1.91 versus $1.61 a year earlier; GAAP diluted EPS of $1.57 versus $1.39
  • Sales revenue of $2.29 billion versus $2.31 billion, with Fibers down 13 percent
  • Net cash used in operating activities of $167 million versus $16 million, driven by inventory build ahead of a planned second-quarter shutdown
  • Second-quarter 2025 adjusted EPS guidance of $1.70 to $1.90; cost reduction target raised to approximately $75 million and capital expenditures reduced to around $550 million

The filing

CompanyEastman Chemical (EMN)
Form8-K, current report
Filed with the SECApr 24, 2025, 4:17 PM ET
Accession number0000915389-25-000099

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.